Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Initiation of insulin for type 2 diabetes mellitus patients: what are the issues? A qualitative study.

Tan AM, Muthusamy L, Ng CC, Phoon KY, Ow JH, Tan NC.

Singapore Med J. 2011 Nov;52(11):801-9.

2.

How do health care professionals assess patients when initiating insulin therapy? A qualitative study.

Lee PY, Lee YK, Khoo EM, Ng CJ.

Prim Care Diabetes. 2014 Apr;8(1):49-55. doi: 10.1016/j.pcd.2013.11.003. Epub 2013 Dec 4.

PMID:
24315732
3.
4.
5.

[Initiating insulin therapy in patients with diabetes mellitus type 2: in a transmural setting is at least as effective as in an outpatient setting; a retrospective study with a 4-year follow-up].

Rosendal H, Vondeling H, de Witte LP, Hutubessy RC, van Beekum WT, Heine RJ.

Ned Tijdschr Geneeskd. 2002 Jan 26;146(4):166-71. Dutch.

PMID:
11845567
6.

FlexPen: addressing issues of confidence and convenience in insulin delivery.

Korytkowski M, Niskanen L, Asakura T.

Clin Ther. 2005;27 Suppl B:S89-100. Review.

PMID:
16519040
7.

Studying the Hurdles of Insulin Prescription (SHIP): development, scoring and initial validation of a new self-administered questionnaire.

Martinez L, Consoli SM, Monnier L, Simon D, Wong O, Yomtov B, Guéron B, Benmedjahed K, Guillemin I, Arnould B.

Health Qual Life Outcomes. 2007 Aug 29;5:53.

8.

Prevalence and reasons for insulin refusal in Bangladeshi patients with poorly controlled Type 2 diabetes in East London.

Khan H, Lasker SS, Chowdhury TA.

Diabet Med. 2008 Sep;25(9):1108-11. doi: 10.1111/j.1464-5491.2008.02538.x.

PMID:
19183316
9.

Barriers to insulin initiation and intensification and how to overcome them.

Kunt T, Snoek FJ.

Int J Clin Pract Suppl. 2009 Oct;(164):6-10. doi: 10.1111/j.1742-1241.2009.02176.x. Review.

PMID:
19751453
10.

Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus.

Braun A, Sämann A, Kubiak T, Zieschang T, Kloos C, Müller UA, Oster P, Wolf G, Schiel R.

Patient Educ Couns. 2008 Oct;73(1):50-9. doi: 10.1016/j.pec.2008.05.005. Epub 2008 Jun 25.

PMID:
18583087
12.

Optimising glycaemic control for patients starting insulin therapy.

Capaldi B.

Nurs Stand. 2007 Jul 11-17;21(44):49-57; quiz 58. Review.

PMID:
17685164
13.

Primary care physician beliefs about insulin initiation in patients with type 2 diabetes.

Hayes RP, Fitzgerald JT, Jacober SJ.

Int J Clin Pract. 2008 Jun;62(6):860-8. doi: 10.1111/j.1742-1241.2008.01742.x. Epub 2008 Apr 3.

14.
15.
16.

[Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].

Hauner H, Kohlmann T, Landgraf W, Holle R, Pirk O, Scholten T.

Dtsch Med Wochenschr. 2009 Jun;134(23):1207-13. doi: 10.1055/s-0029-1222595. Epub 2009 May 26. German. Erratum in: Dtsch Med Wochenschr. 2009 Jun;134(24):1256.

PMID:
19472091
17.

The effect of the availability of inhaled insulin on glycaemic control in patients with Type 2 diabetes failing on oral therapy: the evaluation of Exubera as a therapeutic option on insulin initiation and improvement in glycaemic control in clinical practice (EXPERIENCE) trial.

Del Prato S, Blonde L, Martinez L, Göke B, Woo V, Millward A, Gomis R, Canovatchel B, Strack T, Lawrence D, Freemantle N; EXPERIENCE Trial Team.

Diabet Med. 2008 Jun;25(6):662-70. doi: 10.1111/j.1464-5491.2008.02438.x. Epub 2008 Apr 23.

PMID:
18435781
18.

Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.

Wenying Y, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Ligthelm R, Valensi P; IMPROVE Study Group Expert Panel.

Curr Med Res Opin. 2009 Nov;25(11):2643-54. doi: 10.1185/03007990903276745.

PMID:
19751116
19.

Feature selection and classification model construction on type 2 diabetic patients' data.

Huang Y, McCullagh P, Black N, Harper R.

Artif Intell Med. 2007 Nov;41(3):251-62. Epub 2007 Aug 17.

PMID:
17707617
20.

Initiation of insulin glargine in patients with Type 2 diabetes in suboptimal glycaemic control positively impacts health-related quality of life. A prospective cohort study in primary care.

Hajos TR, Pouwer F, de Grooth R, Holleman F, Twisk JW, Diamant M, Snoek FJ.

Diabet Med. 2011 Sep;28(9):1096-102. doi: 10.1111/j.1464-5491.2011.03329.x.

PMID:
21843305

Supplemental Content

Support Center